PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 67 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,570,354 | -25.0% | 154,098 | +3.4% | 0.02% | -39.4% |
| Q1 2023 | $3,426,816 | +1178.7% | 148,992 | +368.3% | 0.03% | +1550.0% |
| Q3 2022 | $268,000 | -29.5% | 31,814 | -33.8% | 0.00% | -50.0% |
| Q2 2022 | $380,000 | +16.9% | 48,032 | +250.6% | 0.00% | +33.3% |
| Q1 2022 | $325,000 | +45.1% | 13,700 | +174.0% | 0.00% | +50.0% |
| Q2 2021 | $224,000 | -81.8% | 5,000 | -95.1% | 0.00% | -95.5% |
| Q2 2019 | $1,233,000 | +309.6% | 101,800 | +324.2% | 0.04% | +340.0% |
| Q1 2019 | $301,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |